Osamu Nureki Selected Research

Osamu Nureki Research Topics

Disease

16	Neoplasms (Cancer) 03/2024 - 08/2009
5	Inflammation (Inflammations) 01/2022 - 11/2013
4	Bites and Stings (Sting) 10/2018 - 01/2013
3	Virus Diseases (Viral Diseases) 01/2020 - 01/2017
2	Hemophilia B (Haemophilia B) 04/2023 - 01/2017
2	Leukemia 01/2022 - 10/2016
2	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 04/2020 - 05/2018
2	Fibrosis (Cirrhosis) 01/2020 - 01/2017
2	Pulmonary Arterial Hypertension 09/2017 - 01/2016
1	Ischemic Stroke 02/2024
1	Reperfusion Injury 02/2024
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2023
1	Bone Resorption 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Photophobia (Light Sensitivity) 01/2022
1	Overactive Urinary Bladder (Overactive Bladder) 01/2022
1	Dermatitis 12/2021
1	Pemphigus (Pemphigus Vulgaris) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Hypersensitivity (Allergy) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Left Ventricular Dysfunction 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Brain Edema (Cerebral Edema) 01/2019
1	Iron Deficiencies 01/2019
1	Carcinoma (Carcinomatosis) 03/2018
1	Endometriosis 03/2018
1	AIDS-Related Complex (ARC) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Human Influenza (Influenza) 12/2017
1	Alopecia (Baldness) 01/2017
1	Hemophilia A (Haemophilia) 01/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024 - 01/2016
3	Interferon Type IIBA 08/2023 - 01/2013
3	CationsIBA 01/2022 - 02/2016
3	LigandsIBA 01/2022 - 10/2016
3	EnzymesIBA 01/2020 - 04/2013
3	Phosphotransferases (Kinase)IBA 01/2017 - 10/2016
3	Adenosine Triphosphate (ATP)IBA 10/2016 - 04/2013
2	Interleukin Receptor Common gamma SubunitIBA 04/2020 - 05/2018
2	TetraspaninsIBA 01/2020 - 04/2019
2	Lysophosphatidic Acid ReceptorsIBA 01/2020 - 01/2017
2	Endothelins (Endothelin)IBA 01/2020 - 01/2016
2	IronIBA 01/2019 - 10/2015
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2018 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2013
2	Casein Kinase II (Casein Kinase 2)IBA 01/2017 - 10/2016
2	Adenosine Monophosphate (AMP)IBA 01/2017 - 05/2014
1	Bicarbonates (Hydrogen Carbonate)IBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 12/2023
1	Blood Glucose (Blood Sugar)IBA 12/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023
1	Chimeric Antigen ReceptorsIBA 08/2023
1	Interleukin-6 (Interleukin 6)IBA 08/2023
1	CytokinesIBA 08/2023
1	Complementary DNA (cDNA)IBA 04/2023
1	SolutionsIBA 04/2023
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2022
1	mirabegronIBA 01/2022
1	ChannelrhodopsinsIBA 01/2022
1	Parathyroid Hormone-Related ProteinIBA 01/2022
1	Desmoglein 3IBA 12/2021
1	AntigensIBA 12/2021
1	PolyaminesIBA 12/2021
1	Histones (Histone)IBA 11/2021
1	6-methyladenineIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 12/2020
1	Cystine (L-Cystine)IBA 12/2020
1	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2020
1	lysophosphatidic acidIBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2020
1	Large Neutral Amino Acid-Transporter 1IBA 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	Neutral Amino AcidsIBA 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Cell-Free Nucleic AcidsIBA 03/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Protons (Proton)IBA 12/2017
1	Bosentan (Tracleer)FDA Link 09/2017
1	Endothelin Receptors (Endothelin Receptor)IBA 09/2017
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2017
1	AntithrombinsIBA 01/2017
1	2',3'-cyclic GMPIBA 01/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	Antisense OligonucleotidesIBA 01/2017
1	CRISPR-Cas Systems Guide RNAIBA 01/2017
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2017

Therapy/Procedure

5	Therapeutics 11/2022 - 05/2014
2	Immunotherapy 01/2020 - 01/2018
1	Investigational Therapies (Experimental Therapy) 02/2024
1	Hysterectomy 05/2018
1	Drug Therapy (Chemotherapy) 03/2018